157 related articles for article (PubMed ID: 2904881)
1. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group.
Diabetes Care; 1988; 11(7):567-73. PubMed ID: 2904881
[TBL] [Abstract][Full Text] [Related]
2. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.
Am J Med; 1991 Apr; 90(4):450-9. PubMed ID: 2012085
[TBL] [Abstract][Full Text] [Related]
4. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Nicklasson L; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S67-73. PubMed ID: 15324518
[TBL] [Abstract][Full Text] [Related]
5. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
[TBL] [Abstract][Full Text] [Related]
6. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
Purnell JQ; Zinman B; Brunzell JD;
Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
[TBL] [Abstract][Full Text] [Related]
7. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group.
Diabetes Care; 1990 Apr; 13(4):427-33. PubMed ID: 2180661
[TBL] [Abstract][Full Text] [Related]
9. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.
Diabetes Care; 1987; 10(1):1-19. PubMed ID: 2882967
[TBL] [Abstract][Full Text] [Related]
10. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
[TBL] [Abstract][Full Text] [Related]
11. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.
Purnell JQ; Hokanson JE; Marcovina SM; Steffes MW; Cleary PA; Brunzell JD
JAMA; 1998 Jul; 280(2):140-6. PubMed ID: 9669786
[TBL] [Abstract][Full Text] [Related]
12. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Purnell JQ; Braffett BH; Zinman B; Gubitosi-Klug RA; Sivitz W; Bantle JP; Ziegler G; Cleary PA; Brunzell JD;
Diabetes Care; 2017 Dec; 40(12):1756-1762. PubMed ID: 29138273
[TBL] [Abstract][Full Text] [Related]
13. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).
The Diabetes Control and Complications Trial Research Group
Diabetologia; 1998 Apr; 41(4):416-23. PubMed ID: 9562345
[TBL] [Abstract][Full Text] [Related]
14. Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
Nathan DM
Diabetologia; 2021 May; 64(5):1049-1058. PubMed ID: 33550441
[TBL] [Abstract][Full Text] [Related]
15. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
; Nathan DM; Zinman B; Cleary PA; Backlund JY; Genuth S; Miller R; Orchard TJ
Arch Intern Med; 2009 Jul; 169(14):1307-16. PubMed ID: 19636033
[TBL] [Abstract][Full Text] [Related]
16. Adverse events and their association with treatment regimens in the diabetes control and complications trial.
Diabetes Care; 1995 Nov; 18(11):1415-27. PubMed ID: 8722064
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
18. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
Diabetes; 1988 Apr; 37(4):476-81. PubMed ID: 2897940
[TBL] [Abstract][Full Text] [Related]
19. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial.
The Diabetes Control And Complications Trial Research Group
Diabetes Care; 2001 Oct; 24(10):1711-21. PubMed ID: 11574431
[TBL] [Abstract][Full Text] [Related]
20. Muscle sympathetic nerve activity is higher in intensively versus conventionally treated IDDM subjects.
Hoffman RP; Sinkey CA; Anderson EA
Diabetes Care; 1995 Mar; 18(3):287-91. PubMed ID: 7555469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
